A prospective trial of treatment de-escalation following neoadjuvant paclitaxel/trastuzumab/pertuzumab in HER2-positive breast cancer
一项针对HER2阳性乳腺癌患者新辅助紫杉醇/曲妥珠单抗/帕妥珠单抗治疗后降阶治疗的前瞻性试验
期刊:NPJ Breast Cancer
影响因子:7.6
doi:10.1038/s41523-022-00429-7
Waks, Adrienne G; Desai, Neelam V; Li, Tianyu; Poorvu, Philip D; Partridge, Ann H; Sinclair, Natalie; Spring, Laura M; Faggen, Meredith; Constantine, Michael; Metzger, Otto; Alberti, Jillian; Deane, Julia; Rosenberg, Shoshana M; Frank, Elizabeth; Tolaney, Sara M; Krop, Ian E; Tung, Nadine M; Tayob, Nabihah; King, Tari A; Mittendorf, Elizabeth A; Winer, Eric P